Roughly 40 to 76 out of every 100,000 people with type 2 diabetes undergo a limb amputation each year, depending on whether the procedure is major (above or below the knee) or minor (toes or part of the foot). That translates to well under 1% of type 2 diabetics in any given year. In the United States alone, about 130,000 of the 200,000 amputations performed annually occur in people with diabetes, making it the leading cause of non-traumatic limb loss in the country.
Annual Amputation Rates in Type 2 Diabetes
A large systematic review covering 2010 to 2020 found that the incidence of major amputations among people with type 2 diabetes was about 41 per 100,000, while minor amputations ran closer to 76 per 100,000. In practical terms, that means roughly 1 in every 2,500 people with type 2 diabetes faces a major amputation in a given year, and about 1 in 1,300 has a minor one. No reliable lifetime percentage exists because individual risk varies enormously based on blood sugar control, circulation, and whether complications like foot ulcers develop.
These numbers have been climbing in some populations. In one regional time-series analysis, age-adjusted amputation rates among men nearly doubled over a decade, rising from about 8 per 100,000 in 2012 to over 15 per 100,000 in 2021. The sharpest increases were in men aged 45 to 64.
Why Foot Ulcers Are the Main Trigger
About 75% of all lower-limb amputations in people with diabetes are preceded by a foot ulcer. The chain of events usually starts with nerve damage (peripheral neuropathy), which dulls sensation in the feet. A small cut, blister, or pressure sore goes unnoticed, worsens, and becomes infected. At the same time, diabetes often narrows the blood vessels in the legs, starving the wound of the oxygen and nutrients it needs to heal. When infection spreads or tissue dies beyond the point of saving, amputation becomes the remaining option.
Poor blood sugar control accelerates both nerve damage and blood vessel disease, which is why consistently managing glucose levels is the single most effective way to reduce amputation risk. Both type 1 and type 2 diabetes carry similar risks once these complications set in, since the underlying damage to nerves and blood vessels follows the same pattern regardless of diabetes type.
The Role of Poor Circulation
More than half of the nearly 100,000 major leg amputations performed each year in the U.S. involve people who have both diabetes and peripheral artery disease, a condition where plaque buildup narrows the arteries supplying the legs. When blood flow drops below the level needed to sustain tissue, even small wounds can become life-threatening. People in the southern United States have the highest amputation rates in the country, paired with the lowest rates of procedures to restore blood flow, suggesting that access to vascular care plays a significant role in outcomes.
Racial and Gender Disparities
Amputation risk is not spread evenly across demographics. A study of over 640,000 Medicare beneficiaries with diabetic foot ulcers found that Black patients had roughly twice the odds of undergoing an amputation within one year of a foot ulcer diagnosis compared to non-Hispanic white patients. Hispanic patients had 1.65 times the odds, and Asian patients 1.44 times. These gaps persisted even after accounting for age, income, and other health conditions, pointing to systemic differences in the speed and quality of care that different groups receive.
Men face higher amputation rates than women overall. Women with foot ulcers had about 39% lower odds of an early amputation compared to men, though among those who did eventually require amputation, women tended to have theirs later in the course of the disease.
What Happens After an Amputation
Survival after a diabetes-related amputation is better in the short term than many people expect, but long-term outcomes are serious. Among people with diabetes, the 30-day mortality rate after a major leg amputation is about 5%, rising to roughly 13% at one year and 19% at five years. Interestingly, people with diabetes actually had slightly better short-term survival than those without diabetes who underwent the same procedures, likely because diabetic patients tend to be younger at the time of surgery.
The primary driver of death after amputation is not the loss of the limb itself but the underlying vascular disease. One analysis found that the mortality risk from vascular disease was more than 11 times greater than the risk from complications related to reduced mobility after surgery. In other words, the amputation is a marker of how advanced the cardiovascular damage has become, and it is that damage, not the surgery, that most threatens long-term survival.
Reducing Your Risk
The path from diabetes to amputation is long and involves multiple stages where intervention can change the outcome. Keeping blood sugar in your target range slows nerve damage and protects blood vessels. Checking your feet daily for cuts, blisters, redness, or warm spots catches problems before they become ulcers. Wearing properly fitted shoes prevents the kind of repetitive pressure injuries that start the cascade. If you notice a wound that isn’t healing within a week or two, getting it treated early is critical, since the vast majority of amputations begin as treatable foot ulcers.
Regular foot exams, at least once a year with a healthcare provider, can detect nerve damage and circulation problems before they cause visible symptoms. People who already have neuropathy or reduced blood flow benefit from more frequent checkups and, in some cases, referral to a specialist in wound care or vascular health.